Stay updated on Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial
Sign up to get notified when there's something new on the Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial page.

Latest updates to the Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial page
- ChecktodayChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3 revision.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2. No study details or page functionality were changed.SummaryDifference0.0%

- Check44 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1 with no visible changes to study content, layout, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 in the site footer. This is a minor housekeeping update with no impact on content or features.SummaryDifference0.0%

- Check87 days agoChange DetectedLocations section now lists state-specific sites (Alabama, California, Colorado, Illinois, Maryland, Missouri, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Washington) and the page revision is v3.3.3. The HHS Vulnerability Disclosure link was removed.SummaryDifference1%

Stay in the know with updates to Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial page.